BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 19463449)

  • 1. Predictors and outcomes of ad hoc versus non-ad hoc percutaneous coronary interventions.
    Hannan EL; Samadashvili Z; Walford G; Holmes DR; Jacobs A; Sharma S; Katz S; King SB
    JACC Cardiovasc Interv; 2009 Apr; 2(4):350-6. PubMed ID: 19463449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Culprit vessel percutaneous coronary intervention versus multivessel and staged percutaneous coronary intervention for ST-segment elevation myocardial infarction patients with multivessel disease.
    Hannan EL; Samadashvili Z; Walford G; Holmes DR; Jacobs AK; Stamato NJ; Venditti FJ; Sharma S; King SB
    JACC Cardiovasc Interv; 2010 Jan; 3(1):22-31. PubMed ID: 20129564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of sex on 3-year outcome after percutaneous coronary intervention using bare-metal and drug-eluting stents in previously untreated coronary artery disease: insights from the RESEARCH (Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated at Rotterdam Cardiology Hospital) Registries.
    Onuma Y; Kukreja N; Daemen J; Garcia-Garcia HM; Gonzalo N; Cheng JM; van Twisk PH; van Domburg R; Serruys PW;
    JACC Cardiovasc Interv; 2009 Jul; 2(7):603-10. PubMed ID: 19628181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends, predictors, and outcomes of cerebrovascular events related to percutaneous coronary intervention: a 16-year single-center experience.
    Hoffman SJ; Holmes DR; Rabinstein AA; Rihal CS; Gersh BJ; Lennon RJ; Bashir R; Gulati R
    JACC Cardiovasc Interv; 2011 Apr; 4(4):415-22. PubMed ID: 21511221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does prior percutaneous coronary intervention adversely affect early and mid-term survival after coronary artery surgery?
    Yap CH; Yan BP; Akowuah E; Dinh DT; Smith JA; Shardey GC; Tatoulis J; Skillington PD; Newcomb A; Mohajeri M; Pick A; Seevanayagam S; Reid CM
    JACC Cardiovasc Interv; 2009 Aug; 2(8):758-64. PubMed ID: 19695544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous coronary intervention in native arteries versus bypass grafts in prior coronary artery bypass grafting patients: a report from the National Cardiovascular Data Registry.
    Brilakis ES; Rao SV; Banerjee S; Goldman S; Shunk KA; Holmes DR; Honeycutt E; Roe MT
    JACC Cardiovasc Interv; 2011 Aug; 4(8):844-50. PubMed ID: 21851896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of ad hoc percutaneous coronary intervention with drug-eluting stents in angina patients.
    Kim YH; Park DW; Ahn JM; Park GM; Cho YR; Lee JY; Kim WJ; Yun SC; Kang SJ; Lee SW; Lee CW; Park SW; Park SJ;
    EuroIntervention; 2013 May; 9(1):110-7. PubMed ID: 23685299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic impact of periprocedural bleeding and myocardial infarction after percutaneous coronary intervention in unselected patients: results from the EVENT (evaluation of drug-eluting stents and ischemic events) registry.
    Lindsey JB; Marso SP; Pencina M; Stolker JM; Kennedy KF; Rihal C; Barsness G; Piana RN; Goldberg SL; Cutlip DE; Kleiman NS; Cohen DJ;
    JACC Cardiovasc Interv; 2009 Nov; 2(11):1074-82. PubMed ID: 19926047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of severity of renal dysfunction on determinants of in-hospital mortality among patients undergoing percutaneous coronary intervention.
    Parikh PB; Jeremias A; Naidu SS; Brener SJ; Lima F; Shlofmitz RA; Pappas T; Marzo KP; Gruberg L
    Catheter Cardiovasc Interv; 2012 Sep; 80(3):352-7. PubMed ID: 22566286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A global risk approach to identify patients with left main or 3-vessel disease who could safely and efficaciously be treated with percutaneous coronary intervention: the SYNTAX Trial at 3 years.
    Serruys PW; Farooq V; Vranckx P; Girasis C; Brugaletta S; Garcia-Garcia HM; Holmes DR; Kappetein AP; Mack MJ; Feldman T; Morice MC; Ståhle E; James S; Colombo A; Pereda P; Huang J; Morel MA; Van Es GA; Dawkins KD; Mohr FW; Steyerberg EW
    JACC Cardiovasc Interv; 2012 Jun; 5(6):606-17. PubMed ID: 22721655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes for patients with ST-elevation myocardial infarction in hospitals with and without onsite coronary artery bypass graft surgery: the New York State experience.
    Hannan EL; Zhong Y; Racz M; Jacobs AK; Walford G; Cozzens K; Holmes DR; Jones RH; Hibberd M; Doran D; Whalen D; King SB
    Circ Cardiovasc Interv; 2009 Dec; 2(6):519-27. PubMed ID: 20031769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ad hoc percutaneous coronary interventions in patients with stable coronary artery disease--a study of prevalence, safety, and variation in use from the American College of Cardiology National Cardiovascular Data Registry (ACC-NCDR).
    Krone RJ; Shaw RE; Klein LW; Blankenship JC; Weintraub WS;
    Catheter Cardiovasc Interv; 2006 Nov; 68(5):696-703. PubMed ID: 17039514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-eluting versus bare-metal stents in the treatment of patients with ST-segment elevation myocardial infarction.
    Hannan EL; Racz M; Walford G; Holmes DR; Jones RH; Sharma S; Katz S; King SB
    JACC Cardiovasc Interv; 2008 Apr; 1(2):129-35. PubMed ID: 19463290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes following immediate (ad hoc) versus staged percutaneous coronary interventions (report from the 2000 to 2001 New York State Angioplasty Registry).
    Feldman DN; Minutello RM; Gade CL; Wong SC
    Am J Cardiol; 2007 Feb; 99(4):446-9. PubMed ID: 17293181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative outcomes for patients who do and do not undergo percutaneous coronary intervention for stable coronary artery disease in New York.
    Hannan EL; Samadashvili Z; Cozzens K; Walford G; Jacobs AK; Holmes DR; Stamato NJ; Gold JP; Sharma S; Venditti FJ; Powell T; King SB
    Circulation; 2012 Apr; 125(15):1870-9. PubMed ID: 22441935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-eluting stents and the use of percutaneous coronary intervention among patients with class I indications for coronary artery bypass surgery undergoing index revascularization: analysis from the NCDR (National Cardiovascular Data Registry).
    Frutkin AD; Lindsey JB; Mehta SK; House JA; Spertus JA; Cohen DJ; Rumsfeld JS; Marso SP;
    JACC Cardiovasc Interv; 2009 Jul; 2(7):614-21. PubMed ID: 19628183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcome of percutaneous coronary intervention for chronic total occlusions.
    Mehran R; Claessen BE; Godino C; Dangas GD; Obunai K; Kanwal S; Carlino M; Henriques JP; Di Mario C; Kim YH; Park SJ; Stone GW; Leon MB; Moses JW; Colombo A;
    JACC Cardiovasc Interv; 2011 Sep; 4(9):952-61. PubMed ID: 21939934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
    Naganuma T; Chieffo A; Meliga E; Capodanno D; Park SJ; Onuma Y; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Costopoulos C; Kim YH; Buszman PP; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capranzano P; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1242-9. PubMed ID: 24355114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-eluting stent for left main coronary artery disease. The DELTA registry: a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
    Chieffo A; Meliga E; Latib A; Park SJ; Onuma Y; Capranzano P; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Kim YH; Buszman PE; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capodanno D; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
    JACC Cardiovasc Interv; 2012 Jul; 5(7):718-27. PubMed ID: 22814776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical candidacy and selection biases in nonemergent left main stenting: implications for observational studies.
    McNulty EJ; Ng W; Spertus JA; Zaroff JG; Yeh RW; Ren XM; Lundstrom RJ
    JACC Cardiovasc Interv; 2011 Sep; 4(9):1020-7. PubMed ID: 21939943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.